Sign in
SAR Stock Price, Chart, Stats & News
Sareum Holdings plc
Save
Sareum Holdings plc (SAR) does not currently pay a dividend.
51.27M
Market cap
–
Current P/E
95.24x
Forward P/E
SAR chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Sareum Holdings plc operates as a specialized pharmaceutical company, primarily focused on discovering and advancing innovative therapeutic compounds for treating both cancer and autoimmune conditions. The firm develops small-molecule drugs, utilizing its proprietary Sareum Kinase Inhibitor Library as its core drug discovery platform. Its development portfolio currently features programs targeting Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase.
Similar securities
Based on sector and market capitalization
Report issue